Alpha Teknova (NASDAQ:TKNO) Announces Quarterly Earnings Results

Alpha Teknova (NASDAQ:TKNO) announced its earnings results on Tuesday. The company reported ($0.11) EPS for the quarter, Zacks reports. Alpha Teknova had a negative net margin of 87.17% and a negative return on equity of 35.30%. Alpha Teknova updated its FY 2025 guidance to EPS.

Alpha Teknova Stock Up 3.1 %

TKNO stock traded up $0.18 during midday trading on Tuesday, hitting $6.04. The company’s stock had a trading volume of 1,147,962 shares, compared to its average volume of 287,440. The firm has a 50-day simple moving average of $8.32 and a 200-day simple moving average of $6.88. The firm has a market capitalization of $321.98 million, a P/E ratio of -8.16 and a beta of 0.34. The company has a quick ratio of 3.94, a current ratio of 4.73 and a debt-to-equity ratio of 0.12. Alpha Teknova has a 52-week low of $1.15 and a 52-week high of $10.37.

Analyst Ratings Changes

Separately, Craig Hallum began coverage on Alpha Teknova in a report on Monday, February 10th. They set a “buy” rating and a $12.00 target price on the stock.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.